rs121913470, ERBB2

N. diseases: 13
Source: ALL
Disease N. SNPs d DSI v DPI v Chr Position Consequence Alleles Class AFEXOME AFGENOME Score vda EI vda N. PMIDs First Ref. Last Ref.
Mammary Neoplasms
CUI: C1458155
Disease: Mammary Neoplasms
385 0.776 0.200 17 39723967 missense variant T/C;G snv 0.700 1.000 5 2008 2016
Colorectal Neoplasms
CUI: C0009404
Disease: Colorectal Neoplasms
609 0.776 0.200 17 39723967 missense variant T/C;G snv 0.700 1.000 1 2016 2016
Cutaneous Melanoma
CUI: C0151779
Disease: Cutaneous Melanoma
248 0.776 0.200 17 39723967 missense variant T/C;G snv 0.700 1.000 1 2016 2016
Gastric Adenocarcinoma
CUI: C0278701
Disease: Gastric Adenocarcinoma
235 0.776 0.200 17 39723967 missense variant T/C;G snv 0.700 1.000 1 2016 2016
Malignant Uterine Corpus Neoplasm
CUI: C0153574
Disease: Malignant Uterine Corpus Neoplasm
152 0.776 0.200 17 39723967 missense variant T/C;G snv 0.700 1.000 1 2016 2016
Papillary renal cell carcinoma, sporadic
30 0.776 0.200 17 39723967 missense variant T/C;G snv 0.700 1.000 1 2016 2016
Transitional cell carcinoma of bladder
158 0.776 0.200 17 39723967 missense variant T/C;G snv 0.700 1.000 1 2016 2016
Breast Carcinoma
CUI: C0678222
Disease: Breast Carcinoma
2793 0.776 0.200 17 39723967 missense variant T/C;G snv 0.030 1.000 3 2017 2019
Malignant neoplasm of breast
CUI: C0006142
Disease: Malignant neoplasm of breast
3417 0.776 0.200 17 39723967 missense variant T/C;G snv 0.030 1.000 3 2017 2019
Carcinoma breast stage IV
CUI: C0278488
Disease: Carcinoma breast stage IV
14 0.776 0.200 17 39723967 missense variant T/C;G snv 0.010 1.000 1 2015 2015
Hyperactive behavior
CUI: C0424295
Disease: Hyperactive behavior
112 0.776 0.200 17 39723967 missense variant T/C;G snv 0.010 1.000 1 2019 2019
Malignant Neoplasms
CUI: C0006826
Disease: Malignant Neoplasms
1641 0.776 0.200 17 39723967 missense variant T/C;G snv 0.010 1.000 1 2008 2008
Neoplasms
CUI: C0027651
Disease: Neoplasms
1644 0.776 0.200 17 39723967 missense variant T/C;G snv 0.010 1.000 1 2015 2015